ICON (ICLR)
(Delayed Data from NSDQ)
$302.45 USD
+9.91 (3.39%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $302.05 -0.40 (-0.13%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Company Summary
Founded in Dublin, Ireland, in 1990, ICON Public Limited Company (“ICON plc”) is a clinical research organization (CRO). The company is a provider of outsourced development and services to pharmaceutical, biotechnology, medical device and government and public health organizations.
The company offers a full suite of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design to complete execution and post-market commercialization. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process, from compound selection to Phase I-IV ...
Company Summary
Founded in Dublin, Ireland, in 1990, ICON Public Limited Company (“ICON plc”) is a clinical research organization (CRO). The company is a provider of outsourced development and services to pharmaceutical, biotechnology, medical device and government and public health organizations.
The company offers a full suite of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design to complete execution and post-market commercialization. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process, from compound selection to Phase I-IV clinical studies.
The company also provides several services, which include clinical trial management, consulting, contract staffing, data solutions and laboratory services.
The company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries.
In 2021, ICON completed the acquisition of PRA through a merger whereby Indigo Merger Sub, Inc., a subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences. PRA Health Sciences Inc (PRA) is a contract research organization that provides outsourced clinical development and data solution services.
During 2019, ICON enhanced its site and patient recruitment abilities through the strategic acquisitions of MeDiNova and CRN.
General Information
ICON PLC
SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN
DUBLIN 18, L2 00000
Phone: 353-1291-2000
Fax: 353-1247-6260
Email: NA
Industry | Medical Services |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 10/23/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 3.85 |
Current Year EPS Consensus Estimate | 15.09 |
Estimated Long-Term EPS Growth Rate | 15.40 |
Exp Earnings Date | 10/23/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 292.54 |
52 Week High | 347.72 |
52 Week Low | 221.20 |
Beta | 1.22 |
20 Day Moving Average | 582,087.12 |
Target Price Consensus | 370.21 |
4 Week | -9.71 |
12 Week | -7.27 |
YTD | 3.35 |
4 Week | -10.31 |
12 Week | -9.99 |
YTD | -12.52 |
Shares Outstanding (millions) | 82.50 |
Market Capitalization (millions) | 24,133.11 |
Short Ratio | NA |
Last Split Date | 8/13/2008 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 19.39 |
Trailing 12 Months | 20.93 |
PEG Ratio | 1.26 |
vs. Previous Year | 21.96% |
vs. Previous Quarter | 6.80% |
vs. Previous Year | 4.95% |
vs. Previous Quarter | 1.42% |
Price/Book | 2.52 |
Price/Cash Flow | 15.03 |
Price / Sales | 2.90 |
6/30/24 | 12.06 |
3/31/24 | 11.70 |
12/31/23 | 11.42 |
6/30/24 | 6.59 |
3/31/24 | 6.25 |
12/31/23 | 5.95 |
6/30/24 | 1.31 |
3/31/24 | 1.21 |
12/31/23 | 1.21 |
6/30/24 | 1.31 |
3/31/24 | 1.21 |
12/31/23 | 1.21 |
6/30/24 | 13.46 |
3/31/24 | 12.94 |
12/31/23 | 12.54 |
6/30/24 | 8.57 |
3/31/24 | 8.30 |
12/31/23 | 7.54 |
6/30/24 | 9.05 |
3/31/24 | 8.61 |
12/31/23 | 7.69 |
6/30/24 | 116.19 |
3/31/24 | 114.34 |
12/31/23 | 112.02 |
6/30/24 | NA |
3/31/24 | NA |
12/31/23 | NA |
6/30/24 | 0.36 |
3/31/24 | 0.36 |
12/31/23 | 0.40 |
6/30/24 | 26.23 |
3/31/24 | 26.61 |
12/31/23 | 28.40 |